# SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)

> clinical trial · VERIFIED · 2026-07-24

Status: NOT_YET_RECRUITING · Sponsor: Institute of Hematology & Blood Diseases Hospital, China · Condition: PTCL

- Company: Institute of Hematology & Blood Diseases Hospital, China
- Sector: PTCL
- Primary source: https://clinicaltrials.gov/study/NCT07725705

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.